Østergaard søren (15 Ergebnisse)

Hardcover. Zustand: Good. Good hardcover with dustcover. Pages have markings. Covers show minor shelf wear. Binding is tight, hinges are strong. Dust jacket shows edge wear with some rubbing and scuffing. Previous owner's name on end paper. A slight musty smell.; 100% Satisfaction Guaranteed! Ships same or next business day.…

Zustand: New. In English.

Hardcover. Zustand: Brand New. revised edition. 404 pages. 9.25x6.25x1.00 inches. In Stock.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book constitutes the refereed post-proceedings of the 4th IFIP WG 9.7 Conference on the History of Nordic Computing, HiNC 4, held in Copenhagen, Denmark, in August 2014. The 37 revised full papers were carefully reviewed and selected for inclusion in this volume. The papers focus on innovative ICT milestones that transformed the nordic societies and on the new ideas, systems and solutions that helped creating the welfare societies of today, in particular solutions and systems for public services, e.g., tax, social benefits, health care and education; solutions and systems for the infrastructure of the society, e.g., banking, insurance, telephones, transport and energy supply; and technologies and IT policies behind the major IT milestones, e.g., user centric innovation, programming techniques and IT ethics. They are organized in topical sections on IT policy, infrastructure, public services, private services, telesystems, health care, IT in banking, transport and IT technology.…

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New.

Gads Forlag, København 2011. 235 sider. Heftet med orig. omslag. Øverste kapitæl lidt stødt. Ellers pænt eksemplar.

Buch. Zustand: Neu. Trends in Drug Discovery in Diabetes and Obesity | Lars Linderoth (u. a.) | Buch | Trends in Drug Discovery | 304 S. | Englisch | 2026 | Wiley-VCH GmbH | EAN 9783527353309 | Verantwortliche Person für die EU: Wiley-VCH GmbH, Boschstr. 12, 69469 Weinheim, product-safety[at]wiley[dot]com | Anbieter: preigu. …

Buch. Zustand: Neu. Neuware - Drug discovery strategies for next-generation anti-diabetic and anti-obesity therapies Diabetes ranks as the seventh leading cause of death globally, claiming 1.5 million victims annually, yet the complexity of energy metabolism makes pharmaceutical intervention difficult-often requiring simultaneous modulation of multiple drug targets. Trends in Drug Discovery in Diabetes and Obesity assembles drug developers from pharma companies who share hard-to-find insight on strategies for developing more efficient therapies. The book surveys critical drug classes including GLP-1 receptor agonists, GIP antagonists, poly-agonist drugs, and long-acting insulin variants, covering both peptide and small molecule approaches. Selected case studies detail the discovery pathways of recently approved drugs, providing direct insight into the decision-making and optimization processes that led from target identification through clinical validation to market approval. Readers will also find: Reviews of recent therapy developments and emerging treatment paradigms reshaping the current diabetes and obesity pharmacological landscapeEvaluation of poly-agonist drug potential and their projected role in future multi-target therapeutic strategies for metabolic disordersPerspectives from industry professionals across pharmaceutical companies offering practical context rarely available in academic literature aloneCoverage of peptide drug design strategies alongside small molecule approaches for addressing complex metabolic pathway modulation challengesCase studies tracing recently approved drugs from early discovery through optimization, illustrating real-world drug development decision frameworks Designed for medicinal chemists, pharmaceutical chemists, and endocrinologists working in drug discovery and development, this volume delivers the strategic and mechanistic insight needed to advance the next generation of therapeutics targeting diabetes and obesity across both industry and academic research settings.…

Hardcover. Zustand: Brand New. 304 pages. 6.69x0.59x9.61 inches. In Stock.

Buch. Zustand: Neu. Neuware -Drug discovery strategies for next-generation anti-diabetic and anti-obesity therapies Diabetes ranks as the seventh leading cause of death globally, claiming 1.5 million victims annually, yet the complexity of energy metabolism makes pharmaceutical intervention difficult-often requiring simultaneous modulation of multiple drug targets. Trends in Drug Discovery in Diabetes and Obesity assembles drug developers from pharma companies who share hard-to-find insight on strategies for developing more efficient therapies. The book surveys critical drug classes including GLP-1 receptor agonists, GIP antagonists, poly-agonist drugs, and long-acting insulin variants, covering both peptide and small molecule approaches. Selected case studies detail the discovery pathways of recently approved drugs, providing direct insight into the decision-making and optimization processes that led from target identification through clinical validation to market approval. Readers will also find: - Reviews of recent therapy developments and emerging treatment paradigms reshaping the current diabetes and obesity pharmacological landscape- Evaluation of poly-agonist drug potential and their projected role in future multi-target therapeutic strategies for metabolic disorders- Perspectives from industry professionals across pharmaceutical companies offering practical context rarely available in academic literature alone- Coverage of peptide drug design strategies alongside small molecule approaches for addressing complex metabolic pathway modulation challenges- Case studies tracing recently approved drugs from early discovery through optimization, illustrating real-world drug development decision frameworks Designed for medicinal chemists, pharmaceutical chemists, and endocrinologists working in drug discovery and development, this volume delivers the strategic and mechanistic insight needed to advance the next generation of therapeutics targeting diabetes and obesity across both industry and academic research settings.Wiley-VCH GmbH, Boschstraße 12, 69469 Weinheim 304 pp. Englisch.…

Buch. Zustand: Neu. Neuware -Drug discovery strategies for next-generation anti-diabetic and anti-obesity therapies Diabetes ranks as the seventh leading cause of death globally, claiming 1.5 million victims annually, yet the complexity of energy metabolism makes pharmaceutical intervention difficult-often requiring simultaneous modulation of multiple drug targets. Trends in Drug Discovery in Diabetes and Obesity assembles drug developers from pharma companies who share hard-to-find insight on strategies for developing more efficient therapies. The book surveys critical drug classes including GLP-1 receptor agonists, GIP antagonists, poly-agonist drugs, and long-acting insulin variants, covering both peptide and small molecule approaches. Selected case studies detail the discovery pathways of recently approved drugs, providing direct insight into the decision-making and optimization processes that led from target identification through clinical validation to market approval. Readers will also find: - Reviews of recent therapy developments and emerging treatment paradigms reshaping the current diabetes and obesity pharmacological landscape- Evaluation of poly-agonist drug potential and their projected role in future multi-target therapeutic strategies for metabolic disorders- Perspectives from industry professionals across pharmaceutical companies offering practical context rarely available in academic literature alone- Coverage of peptide drug design strategies alongside small molecule approaches for addressing complex metabolic pathway modulation challenges- Case studies tracing recently approved drugs from early discovery through optimization, illustrating real-world drug development decision frameworks Designed for medicinal chemists, pharmaceutical chemists, and endocrinologists working in drug discovery and development, this volume delivers the strategic and mechanistic insight needed to advance the next generation of therapeutics targeting diabetes and obesity across both industry and academic research settings. 304 pp. Englisch.…

People s Press, København 2019. 123 sider. Illustreret med fotos i s/h. Orig. kartonbind. Pænt eksemplar.

Soft cover. Zustand: Fine. 133 pp., illustration, bibliography. In Danish.

orig. wrappers. Zustand: Minor wear. VG. 26x20cm, xi,358 pages., Weighs 850 grams. Series: Det Kongelige Danske Videnskabernes Selskab, Historisk-filosofiske Skrifter, 20.